The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey

被引:58
|
作者
Molteni, Mauro [1 ]
Friz, Hernan Polo [1 ]
Primitz, Laura [1 ]
Marano, Giuseppe
Boracchi, Patrizia
Cimminiello, Claudio [1 ]
机构
[1] Vimercate Hosp, Div Internal Med, Dept Med, I-20871 Vimercate, Italy
来源
EUROPACE | 2014年 / 16卷 / 12期
关键词
Atrial fibrillation; Valvular; Non-valvular; Anti-thrombotic therapy; Stroke; Survey; 2010 ESC GUIDELINES; EUROPEAN-SOCIETY; MEMBER COUNTRIES; WARFARIN; MANAGEMENT; RIVAROXABAN; DABIGATRAN; APIXABAN; STROKE;
D O I
10.1093/europace/euu178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To assess different aspects of the definition of valvular/non-valvular atrial fibrillation (AF) used in clinical practice by physicians who usually treat this condition. Methods and results We prospectively conducted a web-based survey including cardiologists and internists who attended continuing medical education courses on cardiovascular medicine. A questionnaire was drawn up, containing 17 questions clustered into five main topics: (A) known rheumatic aetiology; (B) site/type of valve involvement; (C) prosthetic heart valve; (D) haemodynamic relevance; (E) miscellaneous. The overall response rate was 22.4%(21.1% for cardiologists and 24% for internists). Coexistence of both medical history of rheumatic disease and clinical signs of valvular involvement were considered as essential prerequisites for the diagnosis of rheumatic AF by half of the respondents, and one-third assumed that lone aortic valve disease was sufficient for AF to be defined as valvular. A similar proportion of respondents considered that in the presence of mitral regurgitation, AF had to be defined as valvular. The majority of responding physicians considered the degree of valvular defect of lesser importance for the definition of valvular or non-valvular origin of AF. Conclusion We found important heterogeneity and uncertainties in the answers given by physicians who usually treat patients with AF, as evidence of the lack of precise and unique definitions of the origin of AF (valvular/non-valvular). It is urgent to issue clear widely accepted definitions of the origin of AF, which should improve clinical practice and research.
引用
收藏
页码:1720 / 1725
页数:6
相关论文
共 50 条
  • [31] Electrical cardioversion for non-valvular atrial fibrillation - underestimated risk for thromboembolic complications?
    Klein, H. H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (24) : 1309 - 1311
  • [32] Oral anticoagulation in patients with hypertrophic cardiomyopathy and non-valvular atrial fibrillation in Japan
    Kitaoka, Hiroaki
    Carroll, Robert
    Eugene, Natalie
    Teixeira, Bruno Casaes
    Matsuo, Yukako
    Kubo, Toru
    ESC HEART FAILURE, 2025, 12 (01): : 326 - 337
  • [33] Comparative Effectiveness of Dabigatran versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Alonso, Alvaro
    Chen, Lin Y.
    MacLehose, Richard F.
    Lutsey, Pamela L.
    CIRCULATION, 2013, 128 (22)
  • [34] Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation
    Lee, So-Ryoung
    Choi, Eue-Keun
    Park, Sang-Hyun
    Jung, Jin-Hyung
    Han, Kyung-Do
    Oh, Seil
    Lip, Gregory Y. H.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 415 - 423
  • [35] Direct oral anticoagulants in non-valvular atrial fibrillation in elderly: for a treatment adapted to patient profile
    Tayaa, Said
    Berrut, Gilles
    de Decker, Laure
    Chevalet, Pascal
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2018, 16 (03): : 229 - 240
  • [36] Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial)
    Bunch, Thomas Jared
    May, Heidi
    Cutler, Michael
    Woller, Scott C.
    Jacobs, Victoria
    Stevens, Scott M.
    Carlquist, John
    Knowlton, Kirk U.
    Muhlestein, Joseph B.
    Steinberg, Benjamin A.
    Anderson, Jeffrey L.
    JOURNAL OF ARRHYTHMIA, 2022, 38 (06) : 997 - 1008
  • [37] Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study
    Rahme, Elham
    Godin, Richard
    Nedjar, Hacene
    Dasgupta, Kaberi
    Tagalakis, Vicky
    THROMBOSIS RESEARCH, 2021, 203 : 121 - 130
  • [38] Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure
    Amin, Alpesh
    Reeves, Alessandra B. Garcia
    Li, Xiaoyan
    Dhamane, Amol
    Luo, Xuemei
    Di Fusco, Manuela
    Nadkarni, Anagha
    Friend, Keith
    Rosenblatt, Lisa
    Mardekian, Jack
    Pan, Xianying
    Yuce, Huseyin
    Keshishian, Allison
    PLOS ONE, 2019, 14 (03):
  • [39] Impact of stroke risk factors on warfarin prescription among patients with non-valvular atrial fibrillation
    Zhao, Yu-Hui
    Zhang, Ting
    Du, Xin
    Wen, Dan
    Shang, Mei-Sheng
    Ma, Chang-Sheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (08): : 16587 - 16595
  • [40] Cardioversion in Non-Valvular Atrial Fibrillation
    Klein, Hermann H.
    Trappe, Hans-Joachim
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (50): : 856 - +